Martina DELBECK,Michael HAHN,Thomas MÜLLER,Klemens LUSTIG,Johanna ANLAHR,Karl COLLINS,Janine NICOLAI,Moritz BECK-BROICHSITTER,Udo ALBUS,Doris GEHRING,Björn ROSENSTEIN,Hongkai DANG,Dehe DUAN,Jianfei YA
申请号：
US16622779
公开号：
US20200140461A1
申请日:
2018.06.07
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present application relates to novel imidazopyridinyl- or imidazopyrimidinyl-substituted, bridged 1,4-diazepane derivatives of formula (I), to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases, and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for treatment and/or prevention of respiratory disorders including, sleep-related respiratory disorders such as obstructive sleep apnoeas and central sleep apnoeas and snoring. Formula (I) in which the ring Q represents a bridged 1,4-diazepane cycle
